T1DM - TYPE 1 DIABETES MELLITUS
Clinical trials for T1DM - TYPE 1 DIABETES MELLITUS explained in plain language.
Never miss a new study
Get alerted when new T1DM - TYPE 1 DIABETES MELLITUS trials appear
Sign up with your email to follow new studies for T1DM - TYPE 1 DIABETES MELLITUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to control type 1 diabetes early
Disease control Recruiting nowThis study tests a new drug called CNP-103 in people aged 12 to 35 who were diagnosed with stage 3 type 1 diabetes within the last 6 months. The goal is to see if the drug is safe and can help control the disease. Participants will receive multiple doses of CNP-103 or a placebo o…
Matched conditions: T1DM - TYPE 1 DIABETES MELLITUS
Phase: PHASE1, PHASE2 • Sponsor: COUR Pharmaceutical Development Company, Inc. • Aim: Disease control
Last updated May 17, 2026 06:52 UTC
-
Pig cell transplant could free diabetics from severe low blood sugar
Disease control Recruiting nowThis early-phase study tests a new treatment called OPF-310, which uses pig islet cells enclosed in a protective capsule, for people with unstable type 1 diabetes who still experience dangerous low blood sugar episodes despite using an automated insulin pump and continuous glucos…
Matched conditions: T1DM - TYPE 1 DIABETES MELLITUS
Phase: PHASE1, PHASE2 • Sponsor: Otsuka Pharmaceutical Factory, Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Immune cell therapy aims to save Insulin-Making cells in type 1 diabetes
Disease control Recruiting nowThis early-phase study tests a new treatment called CD7-targeted CAR-T cells in 9 adults with early type 1 diabetes. The therapy uses specially engineered immune cells to target and calm the immune attack on the pancreas, aiming to preserve the body's ability to make insulin and …
Matched conditions: T1DM - TYPE 1 DIABETES MELLITUS
Phase: EARLY_PHASE1 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 14, 2026 12:06 UTC